Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 200,479
  • Shares Outstanding, K 13,401
  • Annual Sales, $ 112,820 K
  • Annual Income, $ -10,880 K
  • EBIT $ -11 M
  • EBITDA $ -5 M
  • 60-Month Beta 0.33
  • Price/Sales 1.68
  • Price/Cash Flow N/A
  • Price/Book 1.43

Options Overview Details

View History
  • Implied Volatility 183.46% (+40.94%)
  • Historical Volatility 61.66%
  • IV Percentile 57%
  • IV Rank 38.25%
  • IV High 435.67% on 01/23/26
  • IV Low 27.25% on 09/09/25
  • Expected Move (DTE 10) 0.26 (1.70%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 23
  • Volume Avg (30-Day) 25
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 624
  • Open Int (30-Day) 624
  • Expected Range 14.71 to 15.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.21
  • Number of Estimates 1
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.88 +51.44%
on 02/13/26
15.01 -0.33%
on 03/09/26
+4.73 (+46.24%)
since 02/09/26
3-Month
9.01 +66.04%
on 01/28/26
15.01 -0.33%
on 03/09/26
+5.44 (+57.14%)
since 12/09/25
52-Week
7.87 +90.09%
on 07/31/25
17.14 -12.72%
on 03/12/25
-1.66 (-9.99%)
since 03/07/25

Most Recent Stories

More News
Anika: Q4 Earnings Snapshot

Anika: Q4 Earnings Snapshot

ANIK : 14.96 (+5.95%)
Anika Reports Fourth Quarter and Full Year 2025 Financial Results

Met 2025 revenue and exceeded revised adjusted EBITDA; reaffirms 2026 revenue and sets adjusted EBITDA target Commercial Channel grew 22% and 15% for Q4 and full year, respectively Generated...

ANIK : 14.96 (+5.95%)
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference

BEDFORD, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Steve Griffin,...

ANIK : 14.96 (+5.95%)
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026

BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...

ANIK : 14.96 (+5.95%)
ANIK INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Anika Therapeutics, Inc.

The law firm of Kirby McInerney LLP continues its investigation on behalf of Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ:ANIK) investors concerning the Company’s...

ANIK : 14.96 (+5.95%)
Anika Therapeutics Announces Leadership Transition

Stephen (Steve) Griffin, Current Chief Financial Officer and Chief Operating Officer, Appointed President and Chief Executive Officer Cheryl Blanchard to Become Executive Chair of the Board of Directors...

ANIK : 14.96 (+5.95%)
ANIK Investigation: Investors Encouraged to Contact Kirby McInerney LLP

The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ:ANIK) investors concerning the Company’s...

ANIK : 14.96 (+5.95%)
Anika: Q3 Earnings Snapshot

Anika: Q3 Earnings Snapshot

ANIK : 14.96 (+5.95%)
Anika Reports Third Quarter 2025 Financial Results

Commercial Channel revenue up 22% with continued strong Integrity ™ Implant System and Hyalofast ® growth, and double-digit International OA Pain Management growth Third and final Hyalofast...

ANIK : 14.96 (+5.95%)
Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study

BEDFORD, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in joint preservation and regenerative solutions, announced that it filed the third and final...

ANIK : 14.96 (+5.95%)

Business Summary

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative...

See More

Key Turning Points

3rd Resistance Point 16.41
2nd Resistance Point 15.71
1st Resistance Point 15.34
Last Price 14.96
1st Support Level 14.26
2nd Support Level 13.56
3rd Support Level 13.19

See More

52-Week High 17.14
Last Price 14.96
Fibonacci 61.8% 13.60
Fibonacci 50% 12.51
Fibonacci 38.2% 11.41
52-Week Low 7.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar